BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

554 hedge funds and large institutions have $16.3B invested in BioMarin Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 195 increasing their positions, 202 reducing their positions, and 51 closing their positions.

Holders
554
Holders Change
+12
Holders Change %
+2.21%
% of All Funds
8.03%
Holding in Top 10
6
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-57.14%
% of All Funds
0.09%
New
66
Increased
195
Reduced
202
Closed
51
Calls
$181M
Puts
$222M
Net Calls
-$41.1M
Net Calls Change
-$92.5M

Top Buyers

1
UBS Group
1
UBS Group
Switzerland
$442M
2
Citadel Advisors
2
Citadel Advisors
Florida
$173M
3
Viking Global Investors
3
Viking Global Investors
Connecticut
$560M
4
Millennium Management
4
Millennium Management
New York
$199M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$118M

Top Sellers

1
Capital Research Global Investors
1
Capital Research Global Investors
California
$570M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$60.8M
3
Deutsche Bank
3
Deutsche Bank
Germany
$204M
4
Parnassus Investments
4
Parnassus Investments
California
$76.2M
5
Morgan Stanley
5
Morgan Stanley
New York
$88.2M
Name Market Value Shares Shares
Change 		Shares
Change %
Primecap Management
1
Primecap Management
California
$1.63B 18,713,895 +299,521 +2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.58B 18,117,108 +67,046 +0.4%
BlackRock
3
BlackRock
New York
$1.26B 14,478,790 -202,854 -1%
Dodge & Cox
4
Dodge & Cox
California
$1.22B 13,992,943 -1,120 -0%
State Street
5
State Street
Massachusetts
$602M 6,895,215 +164,700 +2%
Capital Research Global Investors
6
Capital Research Global Investors
California
$570M 6,520,661 -4,253,980 -39%
Viking Global Investors
7
Viking Global Investors
Connecticut
$560M 6,416,288 +1,526,834 +31%
Ameriprise
8
Ameriprise
Minnesota
$472M 5,403,545 -15,821 -0.3%
Barclays
9
Barclays
United Kingdom
$459M 5,254,520 -34,373 -0.6%
UBS Group
10
UBS Group
Switzerland
$442M 5,056,439 +4,963,987 +5,369%
ACA
11
Avoro Capital Advisors
New York
$381M 4,365,000 +65,000 +2%
EIM
12
Elliott Investment Management
Florida
$306M 3,500,338 +500,000 +17%
Norges Bank
13
Norges Bank
Norway
$304M 3,478,512 +117,202 +3%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$260M 2,986,715 +114,283 +4%
Bank of America
15
Bank of America
North Carolina
$244M 2,789,673 +430,808 +18%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$230M 2,637,488 +77,249 +3%
JPMorgan Chase & Co
17
JPMorgan Chase & Co
New York
$212M 2,422,002 -25,790 -1%
Deutsche Bank
18
Deutsche Bank
Germany
$204M 2,339,236 -1,062,961 -31%
Millennium Management
19
Millennium Management
New York
$199M 2,277,179 +1,108,824 +95%
Citadel Advisors
20
Citadel Advisors
Florida
$173M 1,975,558 +1,620,613 +457%
Pictet Asset Management
21
Pictet Asset Management
Switzerland
$167M 1,905,609 +468,886 +33%
Nomura Holdings
22
Nomura Holdings
Japan
$130M 1,491,255 -641,682 -30%
Point72 Asset Management
23
Point72 Asset Management
Connecticut
$118M 1,345,720 +890,420 +196%
Charles Schwab
24
Charles Schwab
California
$117M 1,341,315 -37,582 -3%
O
25
OrbiMed
New York
$112M 1,278,500 -292,910 -19%
1
2 3 4 5